About this trial
To compare the clinical outcomes of intraperitoneal bupivacaine instillation vs placebo as preemptive analgesia in patients undergoing open appendectomy
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients presenting to the emergency department undergoing open appendectomy.
Disqualifiers
Patients undergoing interval appendectomy or having perforated appendix as evident by examination (abdominal tenderness/ fever) and USG findings (presence of abscess, fluid collection, or free air).
Uncontrolled medical disease (DM: BSL >200mg/dl, HTN: BP >140/90)
History of chronic kidney or liver disease/ psychiatric illness/ Active peptic ulcer disease (as determined on history and medical records)
Alcoholics
Trial design
Parallel
Treatments tested in this trial
Bupivacain
DrugBupivacaine with 0.25% of concentration at the end of the operation intraperitoneally.
Normal Saline
Other intervention10ml of Normal Saline at the end of the operation intraperitoneally.
Treatment groups
Trial outcomes
Primary outcomes
Post operative pain
Intensity of post operative pain by using visual analogue score and frequency of postoperative rescue analgesics if required after instillation of bupivacaine and placebo in both groups. Both outcomes will be noted at different intervals i.e. 2, 6, 12 and 24 hours postoperatively for comparison as mentioned.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Sardar Umer Rehman
Lead sponsor
Services Institute of Medical Sciences, Pakistan
Sponsor institution
Services Institute of Medical Sciences, Pakistan
Collaborator